Dutch-beta thalassemia: A rare mutation from India
Introduction: COVID-19 pandemic imposed challenges towards management of transfusion-dependent thalassemia patients (TDT). The need for regular blood transfusions and iron chelation therapy in these patients added further uncertainty about managing COVID-19 in this subset of patients. Aims: To describe the clinical manifestations of SARS-CoV2 infection in patients with TDT and to evaluate feasibility of home management for patients with mild disease. Materials and methods: The study involved TDT patients registered with thalassemia day care center, DMCH, who tested positive for COVID-19 by RTP... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2022 |
Reihe/Periodikum: | Pediatric Hematology Oncology Journal, Vol 7, Iss 3, Pp 74-76 (2022) |
Verlag/Hrsg.: |
Elsevier
|
Schlagwörter: | COVID-19 / Transfusion dependent thalassemia / Iron chelation therapy / Deferasirox / Pediatrics / RJ1-570 |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-28989447 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | https://doi.org/10.1016/j.phoj.2022.06.001 |